Equities

Dr Miele Cosmed Group SA

Dr Miele Cosmed Group SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (PLN)3.42
  • Today's Change-0.04 / -1.16%
  • Shares traded7.23k
  • 1 Year change+66.83%
  • Beta--
Data delayed at least 15 minutes, as of May 10 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dr Miele Cosmed Group SA, formerly Global Cosmed SA is a Poland-based company active in the cosmetic sector. The Company is engaged in production and distribution of cosmetics and detergents. The Company’s brand portfolio comprises such products as Apart Natural and Malwa, personal wash and care products, Bobini Baby and Bobini, personal wash and care products for kids, Sofin Global, fabric softeners and washing liquids, Kret, cleaning detergents, and Robots, products for dishwashers. The Company sells its products domestically as well as abroad, in such countries as Lithuania, Latvia, Estonia, the Czech Republic, Slovakia, Germany, the Russian Federation, Albania, Kosovo and the United States. The Company is a part of the Dr. Miele Cosmed Group.

  • Revenue in PLN (TTM)444.48m
  • Net income in PLN22.22m
  • Incorporated2001
  • Employees536.00
  • Location
    Dr Miele Cosmed Group SAul. Wielkopolska 3RADOM 26-600PolandPOL
  • Phone+48 483845801
  • Fax+48 483609257
  • Websitehttps://dr-miele.eu/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bialetti Industrie SpA607.74m-22.62m158.53m902.00----5.100.2609-0.034-0.01410.9124-0.1320.89981.185.81156,567.60-3.350.0426-9.340.09867.0665.30-3.720.04790.32730.81681.27--6.132.278.97--8.65--
Culti Milano SpA97.38m5.99m191.82m74.0028.214.7818.131.970.51050.51058.303.010.89871.995.14305,795.704.167.986.6811.6950.3652.544.638.811.16--0.461918.53-2.1028.29-32.99--5.00--
Izmir Firca Sanayi ve Ticaret AS39.02m-3.29m195.95m109.00--12.09--5.02-0.4505-0.45055.342.221.233.6713.372,891,702.00-10.70-5.19-16.32-9.0624.6927.35-8.68-3.981.272.800.2786--3.7155.96-142.72--78.96--
Viking Kagit ve Seluloz A.S.97.42m-38.38m262.57m191.00------2.70-7.38-7.3818.74-2.220.84795.798.333,857,639.00-33.40-15.58-995.46-58.7612.2817.39-39.39-18.300.1763-0.23031.15--126.4733.06-13.92--29.55--
Plastiques du Val de Loire SA3.59bn-70.27m287.55m5.83k--0.28841.820.0801-0.7397-0.739737.7010.471.066.603.55143,109.10-1.64-0.1901-2.90-0.310243.6744.94-1.54-0.20231.112.180.5457--18.454.8328.16---0.8537--
Dr Miele Cosmed Group SA444.48m22.22m298.70m536.0013.441.278.740.6720.25440.25445.092.681.175.2010.03829,248.105.873.608.905.2838.7538.285.003.400.59165.650.2036--12.088.121,080.63--3.79--
Papoutsanis Indtl and Crcl of Cns Gds SA263.27m18.54m304.37m196.0016.412.3210.331.160.15910.15912.261.130.77423.267.85312,129.905.455.857.838.2035.9430.157.046.650.57073.790.427635.92-11.9820.7736.2529.8610.37--
Data as of May 10 2024. Currency figures normalised to Dr Miele Cosmed Group SA's reporting currency: Polish New Zloty PLN
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.